Competing-risks analysis for renal cell carcinoma: how do we accurately communicate the risks and benefits of treatment to patients?

Eur Urol. 2011 Dec;60(6):1160-2; discussion 1162. doi: 10.1016/j.eururo.2011.08.025. Epub 2011 Aug 19.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Carcinoma, Renal Cell / mortality*
  • Carcinoma, Renal Cell / pathology*
  • Female
  • Humans
  • Kidney Neoplasms / mortality*
  • Kidney Neoplasms / pathology*
  • Male